Company Description
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.
The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.
In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.
Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services.
Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
| Country | United States |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,179 |
| CEO | Casey Hoyt |
Contact Details
Address: 625 East Kaliste Saloom Road Lafayette, Louisiana 70508 United States | |
| Phone | 337 504 3802 |
| Website | viemed.com |
Stock Details
| Ticker Symbol | VMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001729149 |
| CUSIP Number | 92663R105 |
| ISIN Number | CA92663R1055 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Casey Hoyt | Chief Executive Officer and Director |
| Michael B. Moore CRT | President |
| Trae Paul Fitzgerald | Chief Financial Officer |
| William Todd Zehnder | Chief Operating Officer and Director |
| Jeremy Trahan | General Counsel and Corporate Secretary |
| Dr. William Dana Frazier M.D. | Chief Medical Officer and Director |
| Jerome Richard Cambre II | Vice President of Sales |
| Michael Freeman | Chief Business Development Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 7, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | 8-K | Current Report |
| May 6, 2025 | 8-K | Current Report |
| Apr 29, 2025 | SCHEDULE 13G/A | Filing |
| Apr 25, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 23, 2025 | SCHEDULE 13G/A | Filing |
| Apr 14, 2025 | 8-K | Current Report |
| Mar 18, 2025 | 8-K | Current Report |